SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

7 Jun 2021 16:37

RNS Number : 0784B
Caledonia Investments PLC
07 June 2021
 

Caledonia Investments plc

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

 

Pursuant to the requirements of the Market Abuse Regulation, Caledonia Investments plc ("Caledonia" or the "Company") announces that on 4 June 2021 the following nil-cost options over ordinary 5p shares in Caledonia were granted to executive directors under the Caledonia Investments 2020 Performance Share Scheme (the "Performance Share Scheme") and in respect of compulsory deferral of bonus under the Caledonia Investments 2020 Deferred Bonus Plan (the "Deferred Bonus Plan"). The Company's share price used to determine the number of Performance Share Scheme awards and Deferred Bonus Plan awards was 3102.5p.

 

Executive Director

No. of shares over which Performance Share Scheme nil-cost options granted

No. of shares subject to Deferred Bonus Plan

J M B Cayzer-Colvin

16,873

4,431

T J Livett

18,868

4,956

W P Wyatt

26,108

6,092

 

Subject to the rules of the Performance Share Scheme, nil-cost options are exercisable between three and ten years after the date of grant. Subject to the rules of the Deferred Bonus Plan, deferred share awards vest after a three year retention period.

 

The total number of awards held by the above-named executive directors of Caledonia under the Company's performance share schemes and deferred bonus plans following these nil-cost option grants are as follows:

 

Executive Director

Total no. of shares held under option under performance share scheme

Total deferred bonus plan share awards

J M B Cayzer-Colvin

92,872

10,050

T J Livett

60,039

4,956

W P Wyatt

147,326

13,652

 

Further information required by the Market Abuse Regulation in relation to these transactions is set out in the appendix below.

 

Enquiries:

Mrs K M Burwood

Deputy Company Secretary

Tel: + 44 20 7802 8080

 

7 June 2021

 

APPENDIX

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

James Michael Beale Cayzer-Colvin

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 5p shares

 

 

GB0001639920

b)

 

Nature of the transaction

 

 

Grant of nil-cost options over ordinary 5p shares under (1) the Caledonia Investments 2020 Performance Share Scheme ("PSS") and (2) the Caledonia Investments 2020 Deferred Bonus Plan ("DBP")

 

c)

 

Price(s) and volume(s)

 

 

 

 

Description

Price(s)

 

Volume(s)

Grant of PSS award

 

£0.00

 

16,873

Grant of DBP award

 

£0.00

4,431

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

21,304

 

Nil

e)

 

Date of the transaction

 

4 June 2021

f)

Place of the transaction

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Timothy James Livett

2

 

Reason for the notification

 

a)

 

Position/status

 

Director/Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 5p shares

 

 

GB0001639920

b)

 

Nature of the transaction

 

 

Grant of nil-cost options over ordinary 5p shares under (1) the Caledonia Investments 2020 Performance Share Scheme ("PSS") and (2) the Caledonia Investments 2020 Deferred Bonus Plan ("DBP")

 

c)

 

Price(s) and volume(s)

 

 

Grant of PSS awards

 

 

 

 

Description

Price(s)

 

Volume(s)

Grant of PSS award

 

£0.00

 

18,868

Grant of DBP award

 

£0.00

4,956

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

23,824

 

Nil

e)

 

Date of the transaction

 

4 June 2021

f)

Place of the transaction

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

William Penfold Wyatt

2

 

Reason for the notification

 

a)

 

Position/status

 

Director/Chief Executive

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 5p shares

 

 

GB0001639920

b)

 

Nature of the transaction

 

 

Grant of nil-cost options over ordinary 5p shares under (1) the Caledonia Investments 2020 Performance Share Scheme ("PSS") and (2) the Caledonia Investments 2020 Deferred Bonus Plan ("DBP")

 

c)

 

Price(s) and volume(s)

 

 

 

 

 

Description

Price(s)

 

Volume(s)

Grant of PSS award

 

£0.00

 

26,108

Grant of DBP award

 

£0.00

6,092

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

32,200

 

Nil

 

e)

 

Date of the transaction

 

4 June 2021

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUGDLLXGDGBR
Date   Source Headline
30th Mar 20162:05 pmRNSTransaction in Own Shares
23rd Mar 201611:54 amRNSDirector/PDMR Shareholding
16th Mar 20164:42 pmRNSDirector/PDMR Shareholding
8th Mar 20163:58 pmRNSDirectorate Change
4th Mar 20169:20 amRNSNet Asset Value(s)
24th Feb 20167:00 amRNSDividend Declaration
22nd Feb 20169:45 amRNSHome Member State Disclosure
4th Feb 20169:41 amRNSNet Asset Value(s)
18th Jan 20162:07 pmRNSDirector/PDMR Shareholding
7th Jan 20162:34 pmRNSInterim Management Statement
7th Jan 20162:23 pmRNSNet Asset Value(s)
4th Jan 20169:49 amRNSBlocklisting Interim Review
21st Dec 20157:00 amRNSAcquisition
8th Dec 20158:14 amRNSHalf Yearly Report
7th Dec 20159:08 amRNSNet Asset Value(s)
19th Nov 20157:00 amRNSHalf Yearly Report
9th Nov 20159:28 amRNSNet Asset Value(s)
26th Oct 20157:00 amRNSAcquisition
7th Oct 20152:20 pmRNSNet Asset Value(s)
30th Sep 20155:26 pmRNSTransaction in Own Shares
29th Sep 20154:18 pmRNSDirector/PDMR Shareholding
28th Sep 20158:12 amRNSDisposal
7th Sep 20153:20 pmRNSNet Asset Value(s)
7th Sep 201512:40 pmRNSAcquisition
1st Sep 201512:45 pmRNSChange of Registered Office
7th Aug 20159:26 amRNSNet Asset Value(s)
29th Jul 201511:32 amRNSForm 8.3 - Quintain Estates & Development
23rd Jul 20154:47 pmRNSDirector/PDMR Shareholding
23rd Jul 20152:04 pmRNSDirector/PDMR Shareholding
16th Jul 201512:49 pmRNSResult of AGM
6th Jul 20153:08 pmRNSInterim Management Statement
6th Jul 20153:07 pmRNSNet Asset Value(s)
1st Jul 20151:09 pmRNSDirector/PDMR Shareholding
1st Jul 20159:45 amRNSBlocklisting Interim Review
26th Jun 20153:42 pmRNSDirector/PDMR Shareholding
22nd Jun 20157:00 amRNSAcquisition
16th Jun 201510:24 amRNSAnnual Financial Report
4th Jun 20151:55 pmRNSNet Asset Value(s)
27th May 20157:00 amRNSFinal Results
11th May 20152:38 pmRNSHolding(s) in Company
11th May 20159:22 amRNSNet Asset Value(s)
30th Apr 201510:30 amRNSDirector Declaration
17th Apr 20153:51 pmRNSHolding(s) in Company
16th Apr 20154:10 pmRNSHolding(s) in Company
15th Apr 20159:15 amRNSHolding(s) in Company
14th Apr 20152:47 pmRNSHolding(s) in Company
14th Apr 20159:38 amRNSDirector Declaration
10th Apr 201512:30 pmRNSHolding(s) in Company
10th Apr 20159:12 amRNSNet Asset Value(s)
1st Apr 20152:58 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.